3PEA International Names Al Negron Senior Vice President Business Development

HENDERSON, Nev.–(BUSINESS WIRE)–3PEA International, Inc. (OTCQB:TPNL),
a vertically integrated provider of innovative prepaid card programs and
processing services for corporate, consumer and government applications,
is delighted to announce the addition of Bio/Pharma copay offset and
reimbursement industry veteran Al Negron to its executive team as Senior
Vice President Business Development in charge of 3PEA’S Healthcare
vertical.

Al is a veteran of the Bio/Pharmaceutical services industry with a
record of over 25 years of success and achievement in accelerating
revenue growth, increasing profitability and expanding market footprints
for his Bio/Pharmaceutical clients. Al has consulted with some of
the most successful brand launch teams and product manufacturers
including Alcon, Allergan, Eli Lilly, Novartis, Mylan and Pfizer. As an
early employee of PSKW, LLC (now ConnectiveRx), Al was prominently
involved with that company’s growth and accomplishments, and in
conjunction with 3PEA International, pioneered the use of prepaid cards
as an immediate payment reimbursement solution for companies such as
Alcon, Genzyme, Actavis, UCB and others. In his new role, Al is
responsible for managing and developing new products and revenue streams
for 3PEA’s Healthcare vertical with special focus on Bio/Pharma copay
offset and reimbursement products in support of pharmaceutical copay
marketing organizations.

Copay offset and reimbursement products are utilized by millions of
prescription holders nationwide to help make prescription drugs and
therapies more affordable. Sponsored by Bio/Pharma companies, it is
estimated that more than $7 billion per year is processed through these
reimbursement products in the US alone.

“Al is uniquely suited for the leadership role he will assume at 3PEA
International” said Mark Newcomer, Chief Executive Officer, 3PEA
International. “Al brings to 3PEA a wide-ranging creative and leadership
background spanning from military service as a logistician and
detachment commander, to manufacturing, quality, marketing and sales.
Moreover, Al’s depth of experience with prepaid card solutions and
immediate payment vehicles as reimbursement tools adds immediate value
to our Bio/Pharma initiatives in support of our management, processing
services and reimbursement card products. We are confident that Al’s
experience and knowledge will be instrumental in expanding 3PEA’s role
in this expansive market.”

About 3PEA International

3PEA International (OTCQB:TPNL)
is an experienced and trusted prepaid card payment solutions provider as
well as an integrated payment processor that has managed millions of
prepaid cards in its portfolio. Through its PaySign brand, 3PEA
conceptualizes, develops and manages payment solutions, prepaid card
programs, and customized payment services. 3PEA’s corporate incentive
prepaid cards are changing the way corporations reward, motivate, and
engage their current and potential customers, employees, and agents.
3PEA’s customizable prepaid solutions offer significant cost savings
while improving brand recognition and customer loyalty. 3PEA’s customers
include healthcare companies, major pharmaceutical companies, large
multinationals, prestigious universities, and social media companies.
PaySign is a registered trademark of 3PEA Technologies, Inc. in the
United States and other countries. For more information visit us at www.3pea.com
or follow us on LinkedIn,
Twitter
and Facebook.

Forward-Looking Statements

Certain statements in this news release may contain forward-looking
information within the meaning of Rule 175 under the Securities Act of
1933 and Rule 3b6 under the Securities Exchange Act of 1934, and are
subject to the safe harbor created by those rules. All statements, other
than statements of fact, included in this release, including, without
limitation, statements regarding potential future plans and objectives
of the companies, are forward-looking statements that involve risks and
uncertainties. There is no assurance that such statements will prove to
be accurate, and actual results and future events could differ
materially. 3PEA undertakes no obligation to publicly update or revise
any statements in this release, whether as a result of new information,
future events, or otherwise.

Contacts

3PEA International, Inc.
Brian Polan, 1-702-749-7234
Chief
Financial Officer
bpolan@3pea.com
www.3pea.com